Valeant Pharmaceutical's (VRX) soap opera continued MondayThe stock fell another 7% to open the week, as its just-dispatched CEO was subpoenaed to testify before the Senate Special Committee on Aging on April 27. The committee is one of two investigating aggressive drug pricing, which has become a hornet's nest and a focus area in front of the upc...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.